204 related articles for article (PubMed ID: 17340610)
1. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Sarkar R; Klein J; Krüger S
Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
[No Abstract] [Full Text] [Related]
3. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
Ak M; Bulut SD; Bozkurt A; Ozsahin A
Adv Ther; 2011 Apr; 28(4):341-8. PubMed ID: 21437763
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
Pessina E; Albert U; Bogetto F; Maina G
Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
[TBL] [Abstract][Full Text] [Related]
5. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study.
Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O
Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781
[TBL] [Abstract][Full Text] [Related]
6. Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Romeo VM; Santoro V; Settineri S; Spina E; Zoccali RA
J Clin Psychopharmacol; 2011 Apr; 31(2):174-9. PubMed ID: 21346614
[TBL] [Abstract][Full Text] [Related]
7. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
Matsunaga H; Hayashida K; Maebayashi K; Mito H; Kiriike N
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):263-9. PubMed ID: 22121999
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
Francobandiera G
J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
[No Abstract] [Full Text] [Related]
9. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.
Masi G; Pfanner C; Millepiedi S; Berloffa S
J Clin Psychopharmacol; 2010 Dec; 30(6):688-93. PubMed ID: 21105283
[TBL] [Abstract][Full Text] [Related]
10. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole induced non-cardiogenic pulmonary edema: a case report.
Cetin M; Celik M; Cakıcı M; Polat M; Suner A
Turk Psikiyatri Derg; 2014; 25(4):287-9. PubMed ID: 25487626
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole augmentation for treatment of patients with inadequate antidepressants response.
Pae CU; Patkar AA; Jun TY; Lee C; Masand PS; Paik IH
Depress Anxiety; 2007; 24(7):522-6. PubMed ID: 17111388
[TBL] [Abstract][Full Text] [Related]
13. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Connor KM; Payne VM; Gadde KM; Zhang W; Davidson JR
J Clin Psychiatry; 2005 Jan; 66(1):49-51. PubMed ID: 15669888
[TBL] [Abstract][Full Text] [Related]
14. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Goldstein RB; Storch EA; Lehmkuhl H; Geffken GR; Goodman WK; Murphy TK
Depress Anxiety; 2009; 26(1):E23-5. PubMed ID: 19067320
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
Uguz F
Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
[TBL] [Abstract][Full Text] [Related]
16. Serotonin reuptake inhibitor-cognitive behavioural therapy-second generation antipsychotic combination for severe treatment-resistant obsessive-compulsive disorder. A prospective observational study.
Tundo A; Salvati L; Cieri L; Balestrini V; Di Spigno D; Orazi F; Iommi M; Necci R
Int J Psychiatry Clin Pract; 2022 Nov; 26(4):395-400. PubMed ID: 35323098
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
18. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).
Sayyah M; Sayyah M; Boostani H; Ghaffari SM; Hoseini A
Depress Anxiety; 2012 Oct; 29(10):850-4. PubMed ID: 22933237
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole augmentation in 13 patients with refractory obsessive-compulsive disorder: a case series.
Higuma H; Kanehisa M; Maruyama Y; Ishitobi Y; Tanaka Y; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
World J Biol Psychiatry; 2012 Jan; 13(1):14-21. PubMed ID: 22256827
[TBL] [Abstract][Full Text] [Related]
20. An aripiprazole discontinuation syndrome.
Philip NS
R I Med J (2013); 2013 Feb; 96(2):13-4. PubMed ID: 24933746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]